Log in

Viking Therapeutics SEC Filings & 10K Form (NASDAQ:VKTX)

$6.40
+0.01 (+0.16 %)
(As of 10/13/2019 04:00 PM ET)
Today's Range
$6.38
Now: $6.40
$6.56
50-Day Range
$6.33
MA: $6.96
$7.64
52-Week Range
$6.15
Now: $6.40
$15.69
Volume1.01 million shs
Average Volume1.59 million shs
Market Capitalization$462.14 million
P/E RatioN/A
Dividend YieldN/A
Beta2.31

SEC Filings

Viking Therapeutics (NASDAQ:VKTX) SEC Filings

DateFilerForm TypeView
10/10/2019
3:02 PM
ArrowMark Colorado Holdings LLC (Filed by)
Viking Therapeutics (Subject)
Form SC 13G/A
08/02/2019
4:59 PM
MORNEAU MICHAEL (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2019
4:16 PM
Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2019
3:24 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2019
3:20 PM
Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
3:15 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2019
3:46 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2019
4:09 PM
Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/10/2019
12:50 PM
STATE STREET CORP (Filed by)
Viking Therapeutics (Subject)
Form SC 13G/A
04/05/2019
3:40 PM
Viking Therapeutics (Filer)
Form DEFA14A
04/05/2019
3:25 PM
Viking Therapeutics (Filer)
Form DEF 14A
03/13/2019
5:54 PM
Viking Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/13/2019
4:01 PM
Viking Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2019
3:12 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
6:53 AM
ArrowMark Colorado Holdings LLC (Filed by)
Viking Therapeutics (Subject)
Form SC 13G
02/13/2019
11:08 AM
FMR LLC (Filed by)
Viking Therapeutics (Subject)
Form SC 13G/A
02/13/2019
9:19 AM
STATE STREET CORP (Filed by)
Viking Therapeutics (Subject)
Form SC 13G
01/22/2019
6:13 PM
MORNEAU MICHAEL (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2019
6:13 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:35 PM
MORNEAU MICHAEL (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:33 PM
Masamune Hiroko (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:31 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:28 PM
Viking Therapeutics (Issuer)
Webster Stephen W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:27 PM
SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:26 PM
FOEHR MATTHEW W (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:22 PM
MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:20 PM
Rowland Charles A Jr (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2018
4:03 PM
LIGAND PHARMACEUTICALS INC (Filed by)
Viking Therapeutics (Subject)
Form SC 13D/A
11/07/2018
4:01 PM
Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/10/2018
9:04 AM
FMR LLC (Filed by)
Viking Therapeutics (Subject)
Form SC 13G
09/27/2018
8:25 PM
LIGAND PHARMACEUTICALS INC (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/21/2018
3:16 PM
Viking Therapeutics (Filer)
Form 424B5
09/21/2018
5:05 AM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2018
3:27 PM
Viking Therapeutics (Filer)
Form 424B5
09/18/2018
6:10 AM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2018
4:11 PM
Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/19/2018
11:15 PM
Viking Therapeutics (Filer)
Form EFFECT
07/11/2018
4:02 PM
Viking Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/03/2018
4:25 PM
Masamune Hiroko (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2018
4:22 PM
Masamune Hiroko (Reporting)
Viking Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/12/2018
6:10 AM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2018
4:13 PM
Viking Therapeutics (Filer)
Form 424B5
06/07/2018
12:41 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2018
8:04 AM
Viking Therapeutics (Filer)
Form S-3MEF
06/06/2018
3:11 PM
Viking Therapeutics (Filer)
Form 424B5
05/31/2018
6:04 PM
SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
6:03 PM
MORNEAU MICHAEL (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
6:02 PM
Rowland Charles A Jr (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
5:59 PM
Viking Therapeutics (Issuer)
Webster Stephen W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
5:57 PM
MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2018
4:02 PM
Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2018
7:37 PM
MORNEAU MICHAEL (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2018
7:37 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2018
3:38 PM
Viking Therapeutics (Filer)
Form DEFA14A
04/06/2018
3:15 PM
Viking Therapeutics (Filer)
Form DEF 14A
03/07/2018
4:16 PM
Viking Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/07/2018
4:11 PM
Viking Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2018
3:14 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2018
3:15 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2018
8:30 AM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2018
3:17 PM
Viking Therapeutics (Filer)
Form 424B5
01/23/2018
4:42 PM
MORNEAU MICHAEL (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2018
4:41 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2018
11:15 PM
Viking Therapeutics (Filer)
Form EFFECT
01/16/2018
4:17 PM
Viking Therapeutics (Filer)
Form 424B3
01/09/2018
4:28 PM
Viking Therapeutics (Filer)
Form S-1/A
12/20/2017
4:21 PM
Viking Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/19/2017
1:23 PM
Farwell Grosvenor Nicholas (Filed by)
Viking Therapeutics (Subject)
Form SC 13G
12/18/2017
8:56 AM
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
Viking Therapeutics (Subject)
Form SC 13G
12/11/2017
3:25 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2017
3:38 PM
Viking Therapeutics (Filer)
Form 424B5
12/06/2017
8:16 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 10/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel